pipette
ESEspañol

Rising Tuberculosis Presentations in Ontario, Canada Are Not Explained by Community SARS-CoV-2 Activity: A Population-Based Time-Series Study

N. J. Wilson, A. Tuite, C. E. Lee, R. J. Berkowitz, B. Wiebe, J. Hall, D. Boushy, D. Fisman

Preprint

In the authors' words

Background: Tuberculosis (TB) notifications have increased in several high-income countries since 2020. Proposed explanations include pandemic related disruption of treatment for latent tuberculosis, changes in population composition, and immune dysfunction following SARS CoV 2 infection. We assessed whether TB presentations increased during the pandemic era and then tested whether community SARS CoV 2 activity was followed by increased mycobacterial disease. Methods: We conducted a population-based ecological time-series study of first TB- and nontuberculous mycobacterial (NTM)-coded hospital, emergency-department and ambulatory clinic presentations in the Greater Toronto/Hamilton Area Plus (GTHA+), Ontario (2024 population approximately 11.2 million), from April 2011 through March 2024. NTM served as a comparator because it shares diagnostic pathways with TB but differs epidemiologically. Negative binomial projection and full-series models estimated pandemic-era changes under three alternative trend assumptions. Distributed lag non linear models estimated cumulative rate ratios for standardized community viral activity over 0 to 12 weeks; sensitivity analyses extended the maximum lag to 26 and 52 weeks. Influenza and respiratory syncytial virus (RSV) were prespecified comparators; data for five additional viral exposures were obtained after the primary analysis was completed and analysed as exploratory comparisons. Results: We identified 3,985 first TB-coded and 5,214 first NTM-coded acute-care presentations. Across six models, estimated pandemic-era TB increases ranged from 3% to 22%. No model suggested an increased in NTM. SARS-CoV-2 activity was not positively associated with TB (cumulative rate ratio per 1-SD increase over 0 to 12 weeks 0.909, 95% CI 0.822 to 1.006) or NTM (0.953, 0.868 to 1.047). No positive associations were identified in subgroup analyses or with maximum lags of 26 or 52 weeks. Influenza was not associated with either outcome. RSV was associated with TB and NTM; only the RSV/NTM association met the Bonferroni threshold among the prespecified comparisons, and no exploratory associations met the experiment wide threshold. Conclusions: We identified a modest pandemic era increase in TB-coded acute-care presentations in Ontario, Canada, although its estimated size depended on assumptions about underlying trends. NTM-coded presentations did not increase. Community SARS-CoV-2 activity was not positively associated with subsequent TB or NTM presentations at lags of up to one year and did not provide a temporal explanation for the population-level TB increase. Individual-level effects cannot be excluded.

Main resultLimitation the authors admit

Appeared: Wednesday, November 18. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.14.26367737